daohang fenxiangbox searchbox qikanlogonew daohangnew searchboxnew navrightzone footerzone paper

Mass production system for RNA-loaded lipid nanoparticles using piling up microfluidic devices AITranslate

Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University;Specialty Chemicals Research Center, Shin-Etsu Chemical Co., Ltd.;Specialty Chemicals Research Center, Shin-Etsu Chemical Co., Ltd.;Specialty Chemicals Research Center, Shin-Etsu Chemical Co., Ltd.; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University
AITranslate
Publisher: Elsevier
Share Citation Information Add to Favorites

    Scan to share on WeChat or Moments

Use WeChat scan.
Share with WeChat friends or Moments

Abstract AITranslate

Highlight • A glass-based microfluidic device for the lipid nanoparticle (LNP) production have been developed. • The glass-based microfluidic device was applied to mRNA-loaded LNP production with ionizable lipids used for COVID-19 mRNA vaccines. • A glass-based microfluidic unit composed of five-layered microchannels was fabricated by piling-up each glass-based device followed by parallelization (numbering-up) for the mass production of LNPs. Microfluidic devices are widely used in lipid nanoparticle (LNP)-based vaccines and nanomedicine research. These devices should be stiff enough to withstand the high flow rate for the mass production of LNPs, and malleable enough to use when fabricating complicated microchannel or micromixer structures, such as staggering herringbone micromixers. Due to the limitations of the available fabrication methods, optimal microfluidic devices have not yet been developed. In this study, we report the development of a glass-based microfluidic device based on the invasive Lipid Nanoparticle Production (iLiNP) device® reported previously. The LNP size controllability of glass-based iLiNP device was similar to that of the poly(dimethylsiloxane) (PDMS)-based iLiNP device, and the glass-iLiNP device was used for mRNA-loaded LNP production with ionizable lipids used for COVID-19 mRNA vaccines. We also demonstrate a piling- and numbering-up strategy based on glass-iLiNP device. The iLiNP unit composed of five-layered microchannels was fabricated by piling-up each glass-iLiNP device followed by parallelization (numbering-up) for the mass production of LNPs. This iLiNP system can produce LNPs with sizes ranging between 20 and 60 nm at a flow rate of 20–50 mL/min, and its performance is comparable to that of the commercially available microfluidic system like NanoAssemblr®. Graphical Download : Download high-res image (292KB) Download : Download full-size image

KeyWords AITranslate

Lipid nanoparticles mRNA vaccines Microfluidic device Microfabrication Mass production
No data

Basic Information:

DOI:https://doi.org/10.1016/j.apmt.2023.101754

Chinese Library Classification Number:

Citation Information:

Highlight • A glass-based microfluidic device for the lipid nanoparticle (LNP) production have been developed. • The glass-based microfluidic device was applied to mRNA-loaded LNP production with ionizable lipids used for COVID-19 mRNA vaccines. • A glass-based microfluidic unit composed of five-layered microchannels was fabricated by piling-up each glass-based device followed by parallelization (numbering-up) for the mass production of LNPs. Microfluidic devices are widely used in lipid nanoparticle (LNP)-based vaccines and nanomedicine research. These devices should be stiff enough to withstand the high flow rate for the mass production of LNPs, and malleable enough to use when fabricating complicated microchannel or micromixer structures, such as staggering herringbone micromixers. Due to the limitations of the available fabrication methods, optimal microfluidic devices have not yet been developed. In this study, we report the development of a glass-based microfluidic device based on the invasive Lipid Nanoparticle Production (iLiNP) device® reported previously. The LNP size controllability of glass-based iLiNP device was similar to that of the poly(dimethylsiloxane) (PDMS)-based iLiNP device, and the glass-iLiNP device was used for mRNA-loaded LNP production with ionizable lipids used for COVID-19 mRNA vaccines. We also demonstrate a piling- and numbering-up strategy based on glass-iLiNP device. The iLiNP unit composed of five-layered microchannels was fabricated by piling-up each glass-iLiNP device followed by parallelization (numbering-up) for the mass production of LNPs. This iLiNP system can produce LNPs with sizes ranging between 20 and 60 nm at a flow rate of 20–50 mL/min, and its performance is comparable to that of the commercially available microfluidic system like NanoAssemblr®. Graphical Download : Download high-res image (292KB) Download : Download full-size image

quote

GB/T 7714-2015 [1] Masatoshi Maeki, Yuto Okada, Shuya Uno, et al. Applied Materials Today, 2023(31). DOI:10.1016/j.apmt.2023.101754.
MLA [1] Masatoshi Maeki, et al., Applied Materials Today, no. 31, 2023, https://doi.org/10.1016/j.apmt.2023.101754.
APA [1] Masatoshi Maeki, Yuto Okada, Shuya Uno, Kaisei Sugiura, Yuichi Suzuki, Kento Okuda, Yusuke Sato, Masao Ando, Hiroyuki Yamazaki, Masaki Takeuchi, Akihiko Ishida, Hirofumi Tani, Hideyoshi Harashima, & Manabu Tokeshi. (2023). Applied Materials Today(31). https://doi.org/10.1016/j.apmt.2023.101754
IEEE [1] Masatoshi Maeki, Yuto Okada, Shuya Uno, Kaisei Sugiura, Yuichi Suzuki, Kento Okuda, Yusuke Sato, Masao Ando, Hiroyuki Yamazaki, Masaki Takeuchi, Akihiko Ishida, Hirofumi Tani, Hideyoshi Harashima, and Manabu Tokeshi, Applied Materials Today, no. 31, 2023, doi: 10.1016/j.apmt.2023.101754. keywords: {Lipid nanoparticles;mRNA vaccines;Microfluidic device;Microfabrication;Mass production}